How Sermorelin Stimulates Growth Hormone
Growth hormone is produced by specialized cells in the anterior pituitary gland. Its secretion is regulated by signals originating in the hypothalamus, particularly growth hormone-releasing hormone and somatostatin.
Sermorelin binds to GHRH receptors on pituitary somatotroph cells and activates the intracellular signaling involved in GH synthesis and release. The result is stimulation of endogenous growth hormone secretion using the body’s own pituitary reserve.
This is an important distinction. Exogenous growth hormone introduces GH directly into circulation, while Sermorelin sends a signal to the pituitary gland and depends on the gland’s ability to respond. The body’s natural regulatory mechanisms therefore remain involved in the process.
GH, IGF-1 and the Recovery Process
Once growth hormone enters circulation, it acts directly on tissues and also stimulates the production of insulin-like growth factor 1 (IGF-1), particularly in the liver. The GH/IGF-1 axis participates in protein metabolism, tissue maintenance, muscle recovery, bone metabolism, and body composition.
For physically active individuals, these pathways are particularly relevant during recovery. Exercise creates controlled stress in muscle and connective tissues, and the subsequent recovery period allows the body to repair and adapt.
Sermorelin is therefore studied in relation to recovery capacity, physical resilience, and maintenance of lean body tissue rather than as a direct muscle-building compound.